Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan · Delayed Price · Currency is TWD 63.30
+0.20 (0.32%)
Jun 25, 2026, 1:30 PM CST
TPE:1720 Market Cap
TPE:1720 has a market cap or net worth of 11.31 billion as of June 25, 2026. Its market cap has increased by 8.02% in one year.
Market Cap
11.31B
Enterprise Value
12.88B
Revenue
7.03B
Ranking
n/a
PE Ratio
11.77
Stock Price
63.30
Market Cap Chart
Since March 4, 1996, TPE:1720's market cap has increased from 2.29B to 11.31B, an increase of 393.08%. That is a compound annual growth rate of 5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 11.31B | 7.47% |
| Dec 31, 2025 | 10.53B | -4.85% |
| Dec 31, 2024 | 11.06B | -6.07% |
| Dec 29, 2023 | 11.78B | 7.15% |
| Dec 30, 2022 | 10.99B | 42.69% |
| Dec 30, 2021 | 7.70B | 14.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTY Biopharm Company | 18.57B |
| Handa Pharmaceuticals | 16.45B |
| ScinoPharm Taiwan | 16.25B |
| Synmosa Biopharma | 15.44B |
| YungShin Global Holding | 14.41B |
| Grape King Bio | 14.35B |
| Foresee Pharmaceuticals | 12.46B |
| Alar Pharmaceuticals | 8.02B |